Attention has recently turned to using plants as hosts for the production of commercially
important proteins. The twelve case studies in this volume present successful strategies for
using plants to produce industrial and pharmaceutical proteins and vaccine antigens. They
examine in detail projects that have commercial potential or products that have already been
commercialized illustrating the advantages that plants offer over bacterial fungal or animal
cell-culture hosts. There are many indications that plant protein production marks the
beginning of a new paradigm for the commercial production of proteins that over the next
decade will expand dramatically.
